Effect of Salt Substitution on Cardiovascular Events and Death
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Salt substitutes with reduced sodium levels and increased potassium levels have been shown to lower blood pressure, but their effects on cardiovascular and safety outcomes are uncertain. METHODS: We conducted an open-label, cluster-randomized trial involving persons from 600 villages in rural China. The participants had a history of stroke or were 60 years of age or older and had high blood pressure. The villages were randomly assigned in a 1:1 ratio to the intervention group, in which the participants used a salt substitute (75% sodium chloride and 25% potassium chloride by mass), or to the control group, in which the participants continued to use regular salt (100% sodium chloride). The primary outcome was stroke, the secondary outcomes were major adverse cardiovascular events and death from any cause, and the safety outcome was clinical hyperkalemia. RESULTS: A total of 20,995 persons were enrolled in the trial. The mean age of the participants was 65.4 years, and 49.5% were female, 72.6% had a history of stroke, and 88.4% a history of hypertension. The mean duration of follow-up was 4.74 years. The rate of stroke was lower with the salt substitute than with regular salt (29.14 events vs. 33.65 events per 1000 person-years; rate ratio, 0.86; 95% confidence interval [CI], 0.77 to 0.96; P = 0.006), as were the rates of major cardiovascular events (49.09 events vs. 56.29 events per 1000 person-years; rate ratio, 0.87; 95% CI, 0.80 to 0.94; P<0.001) and death (39.28 events vs. 44.61 events per 1000 person-years; rate ratio, 0.88; 95% CI, 0.82 to 0.95; P<0.001). The rate of serious adverse events attributed to hyperkalemia was not significantly higher with the salt substitute than with regular salt (3.35 events vs. 3.30 events per 1000 person-years; rate ratio, 1.04; 95% CI, 0.80 to 1.37; P = 0.76). CONCLUSIONS: Among persons who had a history of stroke or were 60 years of age or older and had high blood pressure, the rates of stroke, major cardiovascular events, and death from any cause were lower with the salt substitute than with regular salt. (Funded by the National Health and Medical Research Council of Australia; SSaSS ClinicalTrials.gov number, NCT02092090.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, salt substitution with reduced sodium levels and increased potassium levels has been shown to reduce stroke, CVD, and overall mortality in patients with high CV risk.96”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationSacco, R. L., Kasner, S. E., Broderick, J. P., Caplan, L. R., Connors, J. J. (., Culebras, A., Elkind, M. S. V., George, M. G., Hamdan, A. D., Higashida, R. T., et al. (2013) · Stroke · doi:10.1161/str.0b013e318296aeca · Cited by 3,569
Effect of lower sodium intake on health: systematic review and meta-analyses
Aburto, N. J., Ziolkovska, A., Hooper, L., Elliott, P., Cappuccio, F. P., & Meerpohl, J. J. (2013) · BMJ · doi:10.1136/bmj.f1326 · Cited by 1,242
Self-citationSalt intakes around the world: implications for public health
Brown, I. J., Tzoulaki, I., Candeias, V., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp139 · Cited by 1,173
Self-citationAburto, N. J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 938
Self-citationSodium and Potassium in the Pathogenesis of Hypertension
Adrogué, H. J., & Madias, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064486 · Cited by 763
Huang, L., Trieu, K., Yoshimura, S., Neal, B., Woodward, M., Campbell, N. R. C., Li, Q., Lackland, D. T., Leung, A. A., Anderson, C. A. M., et al. (2020) · BMJ · doi:10.1136/bmj.m315 · Cited by 403
Self-citationCobb, L. K., Anderson, C. A. M., Elliott, P., Hu, F. B., Liu, K., Neaton, J. D., Whelton, P. K., Woodward, M., & Appel, L. J. (2014) · Circulation · doi:10.1161/cir.0000000000000015 · Cited by 300
Self-citationPotassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
Filippini, T., Naska, A., Kasdagli, M., Torres, D., Lopes, C., Carvalho, C., Moreira, P., Malavolti, M., Orsini, N., Whelton, P. K., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015719 · Cited by 271
A Systematic Review of the Sources of Dietary Salt Around the World
Bhat, S., Marklund, M., Henry, M. E., Appel, L. J., Croft, K. D., Neal, B., & Wu, J. H. Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz134 · Cited by 221
Self-citation
Cited by
Items 401–500 of 742
Gan, T.-M., Ke, H., Yang, Y., Mo, G.-L., Wang, S.-R., & Li, J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1660259 · Cited by 4
Lin, J., Wang, H., Xiao, M., Zeng, X., Jiang, L., Zhang, Q., Xie, W., Li, C., Lin, X., Yu, J., et al. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70169 · Cited by 4
“Additionally, the use of potassium-enriched salt substitutes (comprising 20%–30% potassium chloride) instead of traditional salt (100% sodium chloride) has been found to diminish CVD risk [52, 53], making it a promising intervention.”
Self-citationEvolution in the targets for blood pressure treatment
Whelton, P. K., O’Connell, S. S., & Mills, K. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001152 · Cited by 3
Soliman, N., & Soliman, A. T. (2026) · Discover Public Health · doi:10.1186/s12982-026-01366-7 · Cited by 11
Hoorn, E. J., Subramanya, A. R., & Boyd‐Shiwarski, C. R. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01053-5 · Cited by 4
М., Д. О., Васильевна, К. А., & Деев, И. А. (2026) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2025-4698 · Cited by 3
A Focus on Heart Failure Management through Diet and Nutrition: A Comprehensive Review
Liao, L. P., Pant, A., Marschner, S. L., Talbot, P. L., & Zaman, S. J. (2024) · Hearts · doi:10.3390/hearts5030022 · Cited by 6
“These are now more widely available and have been shown to lower salt intake and blood pressure in large clinical trials [38].”
Lundeberg, J. E., Wuopio, J., Mente, A., Måneheim, A., Okrajni, M., Healey, J. S., Sundström, J., Ärnlöv, J., Engström, G., & Johnson, L. (2025) · Heart · doi:10.1136/heartjnl-2024-324391 · Cited by 3
“22 Second, sodium-glucose cotransporter 2 inhibitors, which are known to influence HF prognosis, 23 result in the excretion of sodium in the urine and could therefore plausibly influence PVC frequency.”
Wang, S., Wang, Y., Lü, X., Wang, H., Sun, J., & Wang, X. (2025) · Medicine · doi:10.1097/md.0000000000041543 · Cited by 3
“[42] Nevertheless, even though low-sodium salt is considered safe and efficacious, current data suggest that its impact on reducing the incidence and prognosis of cardiovascular diseases appears to be less favorable than that of most established pharmaceutical interventions.”
Self-citationEffects of salt substitution on cumulative blood pressure: a secondary analysis of the SSaSS
Li, X., Huang, L., Zhou, B., Li, Z., Sun, J., Yu, Y., Song, H., Tian, M., Yin, X., Neal, B. C., et al. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01216-x · Cited by 4
“The study design and primary results have been published previously [15, 16].”
Self-citationShu, J., Xie, C., Gao, L., Wang, Z., Ren, Q., Jin-hai, S., & Yuan, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087905 · Cited by 5
Wu, S., Jiang, S., Yao, Y., & Li, M. (2025) · Coronary Artery Disease · doi:10.1097/mca.0000000000001545 · Cited by 4
KS-WNK1 augments the effects of dietary potassium intake on renal sodium chloride reabsorption
Gamba, G., & Ellison, D. H. (2025) · Journal of Clinical Investigation · doi:10.1172/jci195512 · Cited by 3
“Large randomized clinical trials have also shown recently that potassium supplementation can reduce blood pressure and mortality (6).”
Ferro, K., Seager, R., McManus, K., Kraemer, K. M., Turkson‐Ocran, R., Michetti, J., Allison, S., Fitzpatrick, S. L., & Juraschek, S. P. (2025) · Trials · doi:10.1186/s13063-025-09273-z · Cited by 3
“There is increasing recognition of the importance of home-delivered groceries to promote healthy dietary patterns in the USA and throughout the world [8–10].”
Jaques, D. A., Ponte, B., Olivier, V., de Seigneux, S., Féraille, E., Burnier, M., & Péchère-Bertschi, A. (2023) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2022.12.010 · Cited by 5
Chen, S., Li, H., Wang, S., Yang, S., Liu, S., Song, Y., Li, X., Li, R., Wang, J., Liu, M., et al. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04093-9 · Cited by 5
“It could be partially due to the use of biomass fuel [38] or a diet with high sodium [39].”
BackgroundThe effect of increased plasma potassium on myocardial function; a randomized POTCAST substudy
Winsløw, U., Sakthivel, T., Zheng, C., Philbert, B. T., Vinther, M., Frandsen, E., Iversen, K. K., Bundgaard, H., Jøns, C., & Risum, N. (2023) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-023-02914-x · Cited by 3
“Randomized trials have shown that increased potassium intake and reduced sodium intake are associated with lower rates of major adverse cardiovascular events and death from all causes [7, 27].”
BackgroundGreenwood, H., Barnes, K. A., Ball, L., & Glasziou, P. (2023) · British Journal of General Practice · doi:10.3399/bjgp.2022.0564 · Cited by 6
“28 Other available point estimates show small reductions in CVD mortality risk, but CIs are too imprecise to determine if these are meaningful.”
Yuan, Y., Jin, A., Duan, P., Cao, L., Wang, H., Hu, S., Li, J., Feng, X., Qiao, Q., Zhang, H., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03130-z · Cited by 5
“An alternative, and potentially complementary strategy, is the provision of sodium-reduced, potassium-enhanced table salt for use in cooking and at table, which has been shown in the SSaSS trial [23] in China to reduce both blood pressure and cardiovascular events.”
BackgroundSelf-citationHusain, A. M., Zee, P. C., Leary, E. B., Fuller, D. S., Macfadden, W., Candler, S. A., Whalen, M., & Bae, C. J. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.11.022 · Cited by 4
Evidence on the use of alternative substances and therapies in hypertension
Martín-Rioboó, E., Turégano-Yedro, M., & Banegas, J. R. (2023) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2023.11.001 · Cited by 3
Bullen, J., Kissock, K., Yin, X., Mkambula, P., Trieu, K., Hastings, B. J., Neal, B. C., & Paige, E. (2024) · Public Health Nutrition · doi:10.1017/s1368980024000922 · Cited by 3
“A recent large-scale randomised trial of 20 995 older participants done in rural China showed a 14 % reduction in stroke, 13 % reduction in major CVD and 12 % reduction in all-cause mortality among those using potassium-enriched salt compared with regular salt (9) .”
BackgroundMethodSelf-citationProposed Mechanisms and Associations of COVID-19 with Cardiometabolic Risk Factors
Reddy, K. R., Faridi, K. F., Aggarwal, M., Tirumalai, A. A., Singh, T. K., Tejtel, S. K. S., Williams, K. A., Sr., Litwin, S. E., Dastmalchi, L. N., White, B. A., et al. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241269532 · Cited by 3
Zhang, X., Yao, S., Wang, Y., Chu, C., Du, M., & Mu, J. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70019 · Cited by 3
“A recent clinical study found that replacing 25% of the salt in food with potassium reduced BP levels and the risk of fatal cardiovascular events [4].”
Self-citationMei, X., Qi, Y., Ahmed, Z., Chen, Z., Bai, J., Xiao, W., Liu, S., Yao, Y., & Xu, B. (2025) · Journal of Texture Studies · doi:10.1111/jtxs.70032 · Cited by 3
“It was indicated that potassium supplementation and the prevention of low serum potassium levels could help reduce blood pressure in individuals with hypertension, while those who insisted on a low-potassium diet tended to experience elevated blood pressure (Neal et al. 2021).”
Salt Substitute and Cardiovascular Events and Death
Graudal, N. A., Jűrgens, G., & Alderman, M. H. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2116824 · Cited by 2
Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
Arrarte, V., Campuzano, R., Duque, J. A. A., Aldama, G., Barrios, V., Bonanad, C., Conde, A. C., Olmo, R. F., Gámez, J. M., Guzmán, G., et al. (2022) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2021.10.023 · Cited by 5
“As in other guidelines, very recent publications could not be considered in the recommendations, such as the results of the SSaSS study, 12 presented at the ESC Congress 2021, which found clear cardiovascular benefit with sodium-reduced salt containing 25% potassium chloride, although there were…”
BackgroundSutton’s law and dietary Na+/K+ intake in cardiovascular disease
Messerli, F. H., Muiesan, M. L., & Messerli, A. W. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac283 · Cited by 3
Varghese, J. S., Venkateshmurthy, N. S., Sudharsanan, N., Jeemon, P., Patel, S. A., Thirumurthy, H., Roy, A., Tandon, N., Narayan, K. V., Prabhakaran, D., et al. (2023) · medRxiv · doi:10.1101/2023.06.02.23290909 · Cited by 3
Salt Substitutes—An Important Tool to Increase Potassium and Reduce Sodium Intakes?
McLean, R. M. (2023) · Nutrients · doi:10.3390/nu15122647 · Cited by 3
“These trials demonstrate an association between the use of these salt substitutes and reductions in systolic blood pressure and cardiovascular events [8,9].”
BackgroundThe Apples and Oranges of Blood Pressure Variability
McEvoy, J. W., Leahy, N., & Parati, G. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21927 · Cited by 3
Rosewarne, E., Hoek, A. C., Palu, A., Trieu, K., Taylor, C. B., Ha, D. T. P., Sieburg, M., Ide, N., Buse, K., & Webster, J. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912937 · Cited by 4
“Further, results from a randomized-control trial demonstrated no difference in hyperkalemic events between participants consuming reduced-sodium salts and those consuming regular table salt [20].”
ResultZhang, X., Yin, X., Yap, M. L., Li, R. Q., Huang, L., Liu, Y., Zhou, B., Li, Z., Zhao, Y., Sun, J., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04068-0 · Cited by 4
“The trial demonstrated that switching to sodium-reduced potassium-enriched salt substitutes compared to regular salt lowered blood pressure and protected against stroke, cardiovascular events and premature death [16].”
InfluentialSelf-citationTian, Y., Lin, C., Zhong, H., Wu, C., Wu, Y., Chen, B., Zhang, X., Bai, X., Yang, Y., Wang, Y., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04206-8 · Cited by 3
Self-citationDing, R., Elmadhoun, O., Chen, R., & Ji, X. (2025) · Brain Circulation · doi:10.4103/bc.bc_15_25 · Cited by 4
“[84] Similarly, another large RCT that included more than 20,000 participants with a mean follow-up of 4.7 years also suggested that salt substitution with reduced NaCl and excessive KCl resulted in a 14% reduction of stroke riskand also lowered healthcare costs compared to the nonintervention…”
InfluentialWei, W., Chen, M., Wei, J., & Zheng, X. (2025) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2025.103248 · Cited by 3
How Does Dietary Potassium Influence BP?
Assmus, A. M., Rosenbaek, L. K., & Fenton, R. A. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000988 · Cited by 2
Rethinking Potassium Management in Chronic Kidney Disease—A Modern Approach
Kog, Z. X., Lee, I. W. Z., & Teh, S. P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14248917 · Cited by 4
“However, it is important to note that the study excluded patients who self-reported any history of serious kidney disease and no baseline renal function assessments were performed [78].”
Plant-based oil composition modulates saltiness and bitterness in sodium-reduced double emulsions
Kwon, J., Jeong, J., & Choi, M.-J. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118406 · Cited by 2
Trends in Salt Substitute Use Among Adults in the United States from 2003 to 2020
Wei, Y., Abraham, J., Sandon, L., Wang, J., Price, A. L., Giacona, J. M., & Vongpatanasin, W. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26196 · Cited by 2
Reddy, T. K., Ancha, B., Grant, J. K., & Ferdinand, K. C. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01367-6 · Cited by 3
“In a large trial in China ( N = 20,995 adults), use of potassium-based salt substitutes was associated with lower rates of stroke, major CV events, and all-cause mortality compared with regular salt [45 ].”
The role of community-based blood pressure screening in improving hypertension care
Poulter, N. R., Beaney, T. E., Kerr, G. K., Kiru, G., Schlaich, M., Schutte, A. E., & Stergiou, G. S. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00379-x · Cited by 2
Damman, K., ter Maaten, J. M., Mayne, K. J., Bolignano, D., Brown, E. M., da Costa, B. R., Dagre, A. G., Gansevoort, R. T., Gavina, C., Goette, A., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag098 · Cited by 34
Cheng, H., Yeh, C., Wu, C., Chen, M. Y., Chang, Y., Tsai, H.-H., Chen, Z.-W., Lee, H.-C., Pan, H., Hsu, R.-Y., et al. (2026) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2026.09.040 · Cited by 2
Self-citationYeung, S. M. H., Nooteboom, A., Hoorn, E. J., Rotmans, J. I., Vogt, L., de Boer, R. A., Gansevoort, R. T., Navis, G. J., Bakker, S. J. L., & de Borst, M. H. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac137 · Cited by 2
“On the other hand, a recent trial in >20,000 individuals at cardiovascular risk showed that a salt substitute that partly replaced sodium with potassium salt lowered the risk of mortality and cardiovascular events (5).”
BackgroundTop studies of 2021 relevant to primary care: From the PEER team
Moe, S. S., Perry, D., Thomas, B., Nickonchuk, T., Braschi, É., Dugré, N., Finley, C. R., Lindblad, A. J., Potter, J., & Allan, G. M. (2022) · Canadian Family Physician · doi:10.46747/cfp.6805329 · Cited by 2
Bovet, P., Schutte, A. E., Banatvala, N., & Burnier, M. (2023) · Routledge eBooks · doi:10.4324/9781003306689-10 · Cited by 3
Newer alternatives for resistant hypertension: Beyond 2022 paradigms
Laffin, L. J., Briasoulis, Α., & Bakris, G. L. (2023) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2023.01.006 · Cited by 2
Introduction: Advances in Nutrition Management in Chronic Kidney Disease
Wang, A. Y.-M. (2023) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151445 · Cited by 2
Zou, L., Yu, X., Xiong, J.-H., Chen, C., & Xiao, G. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200783 · Cited by 2
Holvik, K., Abel, M. H., Holmen, J., Krokstad, S., Totland, T. H., & Meyer, H. E. (2024) · Public Health Nutrition · doi:10.1017/s136898002400082x · Cited by 3
“There is also emerging evidence that salt reduction and increased use of potassium based salt substitutes may decrease cardiovascular morbidity and mortality (1,4) .”
BackgroundMacfadden, W., Leary, E. B., Fuller, D. S., Kirby, M. T., & Roy, A. (2024) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11182 · Cited by 3
Adaptive designs in public health: Vaccine and cluster randomized trials go Bayesian
Harari, O., Park, J., Lat, P. K., & Mills, E. J. (2024) · Statistics in Medicine · doi:10.1002/sim.10104 · Cited by 2
Cardiovascular Dynamics in HIV: The Influence of Adrenal Function and Nutritional Status
Niwaha, A. J., & Byrd, J. B. (2024) · Circulation Research · doi:10.1161/circresaha.124.323966 · Cited by 2
Nonpharmacologic Management of Hypertension in Older Adults
Baughman, C., Gong, Y., Wu, Y., Hanlon, E. L., & Juraschek, S. P. (2024) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2024.04.013 · Cited by 4
Self-citationSalt versus no salt restriction in heart failure a review
Raggi, P. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14265 · Cited by 3
“24 The Salt Substitute and Stroke Study 25 was a 5-year study of 21,000 patients with either prior stroke or a high risk of stroke exposed to a sodium/ potassium substitution diet.”
Omage, K., & McCormick, J. A. (2024) · Kidney360 · doi:10.34067/kid.0000000000000527 · Cited by 2
“61,62 This protective effect occurs in part by a reduction in systolic and diastolic BP.”
BackgroundWang, F., Pi, Y.-Y., Zhao, Y., Zhang, Y., Zhou, B., Li, Z., Sun, J., Yu, Y., Tian, M., Yang, M., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03586-7 · Cited by 3
“All statistical analyses applied the same statistical methodology as used for the main trial analyses [24] and were performed using an intention-to-treat approach.”
BackgroundMethodSelf-citationBlood L‐cystine levels positively related to increased risk of hypertension
Chen, H., Deng, Y., Zhou, H., Wu, W., Bao, J., Cao, D., Li, Y., & Feng, Y. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14902 · Cited by 3
Yao, Y., Zhang, Z.-X., Yin, S.-F., Wu, S., & Liu, Z. (2024) · World Journal of Cardiology · doi:10.4330/wjc.v16.i12.731 · Cited by 2
“A predominant risk factor in the Chinese population for cerebrovascular and cardiovascular conditions, including representative hypertension, is a high-salt diet[20,21].”
Liu, M., Xu, J., Li, Y., He, F. J., Zhang, P., Song, J., Gao, Y., Yan, S., Yan, W. Q., Jin, D., et al. (2024) · Nutrients · doi:10.3390/nu16234092 · Cited by 2
“A multifaceted comprehensive intervention strategy for salt reduction was proposed, drawing on evidence from previous studies [2,13,14].”
Salt added at the table, APOE genotype and incident dementia
Ren, J.-J., Li, Z., Zhong, W.-F., Chen, P., Wang, X.-M., Song, W.-Q., & Mao, C. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108183 · Cited by 2
Self-citationCoordinated Regulation of Renal Glucose Reabsorption and Gluconeogenesis by mTORC2 and Potassium
Demko, J. E., Saha, B., Takagi, E., Manis, A. D., Weber, R. J., Koepsell, H., & Pearce, D. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000703 · Cited by 3
Mor, N. (2025) · Discover Health Systems · doi:10.1007/s44250-025-00218-6 · Cited by 2
“There is accumulating evidence that a reduction in this excess consumption of salt and the use of salt substitutes where necessary have significant benefits for individuals and populations through the control of hypertension, a major risk factor for the burden of disease in Odisha [81, 83–85].”
Les meilleures études de 2021 adéquates pour les soins de première ligne: De l’équipe du groupe PEER
Moe, S. S., Thomas, B., Kolber, M. R., Korownyk, C. S., Lindblad, A. J., Dugré, N., Turgeon, R. D., Braschi, É., & Allan, G. M. (2022) · Canadian Family Physician · doi:10.46747/cfp.6805334 · Cited by 1
Can these salt substitutes prevent complications of hypertension?
Chang, E., Powell, R., & Reese, T. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0667 · Cited by 3
“The Salt Substitute and Stroke Study (SSaSS), published in 2021, demonstrated the protective effect of salt substitution against stroke, other CV events, and death.(14)”
BackgroundKann eine Salzsubstitution oder -reduktion bei arterieller Hypertonie Arzneimittel ersetzen?
Zidek, W. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01312-0 · Cited by 2
Reduction of salt intake: time for more action
Jones, E. S. W., Lee, H., Khan, N. A., Charchar, F. J., Williams, B., Chia, Y. C., & Tomaszewski, M. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003262 · Cited by 2
“The recent study substituting potassium chloride for sodium chloride, performed in China, demonstrates the clear benefit of sodium-potassium balance [26].”
BackgroundEconomic burden for the Unified Health System attributable to excessive sodium consumption in Brazil
Guedes, L. F. F., Vegi, A. S. F., Felisbino-Mendes, M. S., de Menezes, M. C., Meireles, A. L., Malta, D. C., & Machado, Í. E. (2024) · Public Health · doi:10.1016/j.puhe.2024.01.002 · Cited by 2
Appel, L. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00165-7 · Cited by 2
Advances in Stroke: Treatments-Preventive
Sandset, E. C., & Goldstein, L. B. (2023) · Stroke · doi:10.1161/strokeaha.123.042097 · Cited by 2
Engberink, R. O. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.026 · Cited by 2
Desai, R., Heller, J., Wada, R., Afnan, M. A. M., Cheong, C., Zhang, S., Deo, F., Tam, M., Anderson, E. L., Stott, J. C. H., et al. (2025) · medRxiv · doi:10.1101/2025.03.12.25323830 · Cited by 2
Self-citationKario, K. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26487 · Cited by 2
Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus
Barcellos, P. A. M., Dall’Agnol, A., Sandi, G. M., Remonti, L. R., & Silveiro, S. P. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003674 · Cited by 1
Conocimiento del riesgo cardiovascular y consumo de sal/sodio en estudiantes de ciencias de la salud
Ríos, O. G. V., Aguayo-Cabana, A. R., Hiyo-Huapaya, E. P., Riojas-Yance, Z. D. L. Á., Becerra-Medina, L. T., Rojas, J. S., Ponte-Valverde, S. I., & Narváez, S. E. R. (2024) · Investigación e Innovación Revista Científica de Enfermería · doi:10.33326/27905543.2024.1.1911 · Cited by 1
Shakthivel, C. D. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-2703-6.ch005 · Cited by 2
Liu, J., Zheng, H., Liu, S., Kwan, T. K., Gurung, R. L., Chan, C., Lee, J., Ang, K., Keizer, J. D., Hadjadj, S., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02546-y · Cited by 3
Smith, S. C., & Taubert, K. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-79051-5_2 · Cited by 5
Dietary Sodium- and Potassium-Enriched Salt Substitutes—The Tipping Point?
Jones, D. W., Egan, B. M., & Lackland, D. T. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2024.5430 · Cited by 1
Pathophysiology of the Antihypertensive and Cardiovascular Properties of Potassium
Chrysant, S. G. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000841 · Cited by 1
Wu, A., Wolley, M. J., Vesey, D. A., Terker, A. S., Welling, P. A., Fenton, R. A., & Stowasser, M. (2025) · Nephrology · doi:10.1111/nep.70017 · Cited by 2
Chun, C. T., MacDonald‐Wicks, L. K., English, C., Lannin, N. A., Janssen, H., Davey, J., Kempson, C., Hopper, B., & Patterson, A. J. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70045 · Cited by 1
Yano, Y., Kitaoka, K., Ohkubo, T., Okamura, T., Kanegae, H., Yoshita, K., Tsukinoki, R., Okami, Y., Node, K., Rakugi, H., et al. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf049 · Cited by 1
Hypertension-Based Chronic Disease
Correia, E. T. D. O., & Mechanick, J. I. (2025) · Springer eBooks · doi:10.1007/978-3-031-82888-1_4 · Cited by 1
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251343907 · Cited by 3
Na and K Content and Na/K Ratio of Ramen Dishes Served in Ramen Restaurants in Kyoto City, Japan
Okuda, N., Kojima, H., Nagahata, T., & Okayama, A. (2025) · Dietetics · doi:10.3390/dietetics4020021 · Cited by 2
Crowther, J., Hoek, A. C., Trieu, K., Denham, I., Deltetto, I., Balaguer‐Mercado, A., Bullen, J., Kissock, K., Patay, D., Rosewarne, E., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-23717-w · Cited by 1
“However, no harm has been found in any potassium-enriched salt trial to date, including trials in people with potentially undiagnosed CKD and elderly participants at higher risk of hyperkalaemia [16, 44].”
Self-citationStrengthening salt reduction strategies in the out-of-home food sector: warning labels and beyond
Pineda, E. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(25)00168-9 · Cited by 1
High Salt Intake and Cardiovascular Disease: An Overview
Surma, S., Francuz, T., & Ciechanowski, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_190-1 · Cited by 3
Zhao, X. H., Chen, Y., Zhao, K., Wei, Y., Zhang, Y., Liu, K., & Shi, L. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin42286 · Cited by 1
“Disruptions lead to severe health issues including hypertension and heart disease [1].”
Self-citationYounas, S., Parvathi, H., Sahu, S., Rani, R., Saher, S., Chatzizisis, Y. S., & Delgado-Lelievre, M. C. (2025) · Journal of Vascular Diseases · doi:10.3390/jvd4040042 · Cited by 1
“In the 20,000-person SSaSS trial, the rate of serious adverse events attributed to hyperkalemia was not higher with the salt substitute than with regular salt [6,11].”
InfluentialSafety and Efficacy of Salt Restriction Across the Spectrum of Heart Failure
Stachteas, P., Nasoufidou, A., Koiliari, M., Arampatzi, V., Alexaki, C., Kofos, C., Karakasis, P., Karagiannidis, E., Koufakis, T., Fragakis, N., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12110432 · Cited by 2
“Numerous studies and meta-analyses confirm that reducing sodium -even with interventions such as salt substitutes—lowers BP (both systolic and diastolic), improves general cardiovascular health and decreases cardiovascular morbidity and mortality [75–77].”
Crouch, S. H., Ware, L. J., Norris, S. A., & Schutte, A. E. (2025) · Trials · doi:10.1186/s13063-025-09184-z · Cited by 1
“…substitutes reduced the risk of major adverse cardiovascular events (rate ratio, 0.87; 95% CI 0.80 to 0.94; P < 0.001), stroke (rate ratio, 0.86; 95% CI 0.77 to 0.96; P = 0.006), and led to a reduction in BP (mean difference in systolic BP; − 3.34 mm Hg (95% CI − 4.51 to − 2.18) over 5 years [6].”
InfluentialYin, X., Huang, L., Tian, M., Song, H., Ding, X., Jha, V., Kotwal, S. S., Marklund, M., Liu, Y., Zhang, X., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.075690 · Cited by 1
Self-citationMoissl, A. P., Delgado, G. E., Yücel, G., Daschner, C., Kleber, M. E., Krämer, B. K., März, W., & Yazdani, B. (2025) · Cardiorenal Medicine · doi:10.1159/000549495 · Cited by 1
“Randomised trials of salt substitution with potassium chloride have shown significant reductions in CV events and mortality [30].”
Gut microbiota-driven diseases and intervention strategies – lessons from China
Zhou, Y., Gong, T., Yi, C., Yang, W., Ye, G., Xiao, D., Cao, Y., Xiong, Y., Ibáñez, E., Cifuentes, A., et al. (2025) · npj Science of Food · doi:10.1038/s41538-025-00610-9 · Cited by 1
Zhang, Z., Xu, Y., Nie, K., Deng, T., & Xia, L. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf222 · Cited by 1
Cost-Effectiveness of Expanding Home Cook Interventions for Salt Reduction in China
Li, X., Lv, Y., Gao, X., Fan, B., He, Y., Zhao, S., Liu, F., Li, N., Wu, Q., Li, W., et al. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108203 · Cited by 2
Self-citationDuncan, J. P., Tulloch-Reid, M. K., Ferguson, T. S., Land, M., & Neal, B. C. (2026) · Public Health in Practice · doi:10.1016/j.puhip.2026.100726 · Cited by 1
“Large clinical trials show that salt substitutes provide benefits for normotensive and hypertensive persons [14,15] with protection against stroke, major cardiovascular events and premature death [16,17].”
Self-citation
Metadata
- Authors
- Neal, B., Wu, Y., Feng, X., Zhang, R., Zhang, Y., Shi, J., Zhang, J., Tian, M., Huang, L., Li, Z., Yu, Y., Zhao, Y., Zhou, B., Sun, J., Liu, Y., Yin, X., Hao, Z., Yu, J., Li, K.-C., Zhang, X., Duan, P., Wang, F., Ma, B., Shi, W., Di Tanna, G. L., Stepien, S., Shan, S., Pearson, S.-A., Li, N., Yan, L. L., Labarthe, D., & Elliott, P.
- Affiliations
- The George Institute for Global Health (GB)
- Harbin Medical University (CN)
- From the George Institute for Global Health (B.N., M.T., L.H., Y.L., X.Y., J.Y., K.-C.L., G.L.D.T., S. Stepien, S. Shan) and the Centre for Big Data Research in Health (S.-A.P.), University of New South Wales, and George Clinical (N.L.) — all in Sydney; the School of Public Health (B.N., K.-C.L., P.E.), the U.K. Dementia Research Institute (P.E.), the British Heart Foundation Centre for Research Excellence (P.E.), and the NIHR Imperial Biomedical Research Centre (P.E.), Imperial College London, Health Data Research (P.E.), the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards (P.E.), and the Medical Research Council Centre for Environment and Health (P.E.) — all in London; Peking University Clinical Research Center, Peking University (Y.W.), the George Institute for Global Health at Peking University Health Science Center (Y.W., M.T., Z.H., X.Z., L.L.Y.), and the Department of Cardiology, Peking University Third Hospital (J.Y.), Beijing, the School of Public Health, Changzh...
- Northwestern University (US)
- ORCID
- Neal, Bruce
- Wu, Yangfeng
- Zhang, Ruijuan
- Zhang, Yuhong
- Shi, Jingpu
- Zhang, Jianxin
- Tian, Maoyi
- Huang, Liping
- Li, Zhifang
- Yu, Yan
- Zhao, Yi
- Zhou, Bo
- Liu, Yishu
- Yin, Xuejun
- Yu, Jie
- Zhang, Xinyi
- Duan, Peifen
- Wang, Faxuan
- Ma, Bing
- Shi, Weiwei
- Stepien, Sandrine
- Shan, Sana
- Pearson, Sallie-Anne
- Li, Nicole
- Yan, Lijing L.
- Labarthe, Darwin
- Elliott, Paul
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-16
- Volume
- 385
- Issue
- 12
- Pages
- 1067-1077
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198627281
- Cited by
- 742
- References
- 21
- Citations by year
- 2026: 119 · 2025: 165 · 2024: 131 · 2023: 168 · 2022: 133 · 2021: 24
- FWCI
- 72.81
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1049417, APP1164206)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- salt substitutes, potassium chloride, sodium chloride, hypertension, stroke prevention, major adverse cardiovascular events, mortality, hyperkalemia, blood pressure, older adults, rural China, dietary salt reduction, secondary stroke prevention, cost-effectiveness
- MeSH terms
- Aged, Cardiovascular Diseases, China, Diet, Sodium-Restricted, Female, Humans, Hyperkalemia, Hypertension, Male, Middle Aged, Mortality, Potassium, Dietary, Stroke, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.